Actualités Valeritas Holdings Inc - VLRX | Actions NASDAQ

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...

Valeritas to Report Second Quarter 2019 Financial Results on August 8, 2019

BRIDGEWATER, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Th...

BRIDGEWATER, N.J., July 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...

Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable In...

BRIDGEWATER, N.J., June 27, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold

BRIDGEWATER, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________...

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a B...

BRIDGEWATER, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., May 31, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________...

Valeritas to Participate in the American Diabetes Association’s 79th Scientific Sessions; Company Reiterates Second Quarte...

BRIDGEWATER, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Valeritas Holdings Inc (VLRX)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

VLRX Actualités

Current Report Filing (8-k)

Valeritas to Report Second Quarter 2019 Financial Results on August 8, 2019

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Th...

Current Report Filing (8-k)

Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable In...

Current Report Filing (8-k)

Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold

Current Report Filing (8-k)

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a B...

Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Current Report Filing (8-k)

Valeritas to Participate in the American Diabetes Association’s 79th Scientific Sessions; Company Reiterates Second Quarte...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Valeritas Holdings Inc (VLRX) Actualités

Valeritas Holdings Inc (VLRX)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

VLRX Actualités

Current Report Filing (8-k)

Valeritas to Report Second Quarter 2019 Financial Results on August 8, 2019

Current Report Filing (8-k)

Current Report Filing (8-k)

Current Report Filing (8-k)

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Economic Advantages Compared to Multiple Daily Injection Th...

Current Report Filing (8-k)

Valeritas Files Special 510(k) with FDA for Labeling Change to Include the Use of Regular Human Insulin In V-Go® Wearable In...

Current Report Filing (8-k)

Valeritas Announces Milestone of 20 Million V-Go® Insulin Delivery Devices Sold

Current Report Filing (8-k)

Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates a Reduction in A1c Levels by 1.3 when Intensifying from a B...

Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Current Report Filing (8-k)

Valeritas to Participate in the American Diabetes Association’s 79th Scientific Sessions; Company Reiterates Second Quarte...

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application